Acute Schizophrenia
According to a recent study, a new drug called lurasidone is safe and effective for treating patients hospitalized for acute schizophrenia. The study looked at the effects of the experimental drug in 829 patients who were given either 40, 80, or 120 mg doses of lurasidone for up to six weeks. The researchers found that patients taking the 120 mg dose showed more improvement in their schizophrenia symptoms than patients taking the lower doses. Scientists added that the patients were at low risk...
Read moreMore information on "Acute Schizophrenia"
From Our Experts
Schizophrenia Drugs: The Latest Developments
This SharePost will be devoted to schizophrenia drugs in the pipeline. Bioline RX enrolled its first patient in their Phase II/III... Read more »
Schizophrenia: Latest Research September 2011
Australian researchers' experiments with mice resulted in the first experimental demonstration that babies of older males are at increased... Read more »
Schizophrenia: Latest Drug Treatments
This SharePost is the first of a series devoted to schizophrenia treatment and it focuses specifically on some of the newer drugs used to... Read more »
Schizophrenia News: December 2010
Each month I'd like to report on breaking news in the mental health field. To begin: Dainippon Sumitomo is bringing Latuda to the... Read more »
Schizophrenia in the News: July 2011
I'm writing this SharePost to generate a discussion on the endless hot topic of schizophrenia in the news. We'll return to the topic... Read more »
From Our Sources
Schizophrenia
Source: HealthCentral Encyclopedia
Article updated and reviewed by Christos Ballas, MD, Attenting Psychiatrist, Inpatient and Consult/Liaison Psychiatry, Hospital of the University of... Read more »
Clinical trial: Invega versus Seroquel in patients with schizo...
This is a study to compare the effectiveness of Invega to Seroquel in patients who are acutely ill with symptoms of schizophrenia. This international... Read more »
New schizophrenia drug's trial halted
Phase III clinical trials on a new drug to treat schizophrenia have been stopped, its makers report. Officials with drugmakers Lundbeck and Solvay... Read more »
FDA panel recommends new bipolar, schizophrenia drug
An expert panel that advises the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend a new drug for bipolar I disorder and... Read more »
New bipolar, schizophrenia med goes to FDA
The U.S. Food and Drug Administration has agreed to review a new medication to treat bipolar disorder and schizophrenia. The med, asenapine, is a... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
